TriplePoint Venture Growth BDC (TPVG) Set to Announce Earnings on Wednesday

TriplePoint Venture Growth BDC (NYSE:TPVG) is projected to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect TriplePoint Venture Growth BDC to announce earnings of $0.22 per share and revenue of $22.18 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 5:00 PM ET.

TriplePoint Venture Growth BDC (NYSE:TPVG) last released its earnings results on Wednesday, August 5th. The investment management company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The business had revenue of $22.15 million during the quarter, compared to analyst estimates of $22.88 million. On average, analysts expect TriplePoint Venture Growth BDC to post $0.89 EPS for the current fiscal year and $0.84 EPS for the next fiscal year.

TriplePoint Venture Growth BDC Stock Performance

Shares of NYSE TPVG opened at $4.37 on Wednesday. TriplePoint Venture Growth BDC has a one year low of $4.15 and a one year high of $6.95. The company’s fifty day moving average is $4.91 and its two-hundred day moving average is $5.24.

TriplePoint Venture Growth BDC Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Wednesday, December 16th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 5.5%. This is a negative change from TriplePoint Venture Growth BDC’s previous quarterly dividend of $0.29. The ex-dividend date is Wednesday, December 16th.

Wall Street Analyst Weigh In

TPVG has been the subject of several research analyst reports. Keefe, Bruyette & Woods dropped their price objective on TriplePoint Venture Growth BDC from $6.00 to $5.50 and set a “market perform” rating for the company in a research note on Thursday, August 6th. Weiss Ratings lowered shares of TriplePoint Venture Growth BDC from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. Finally, Piper Sandler lowered their price objective on shares of TriplePoint Venture Growth BDC from $5.50 to $5.00 and set a “neutral” rating on the stock in a research note on Monday, July 13th. Three investment analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $5.17.

Insider Activity at TriplePoint Venture Growth BDC

In other news, CEO James Labe bought 313,865 shares of the firm’s stock in a transaction that occurred on Friday, September 18th. The shares were purchased at an average price of $4.71 per share, for a total transaction of $1,478,304.15. Following the completion of the transaction, the chief executive officer owned 2,312,354 shares in the company, valued at $10,891,187.34. The trade was a 15.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Sajal Srivastava sold 313,865 shares of TriplePoint Venture Growth BDC stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $4.71, for a total transaction of $1,478,304.15. The SEC filing for this sale provides additional information. Corporate insiders own 1.55% of the company’s stock.

TriplePoint Venture Growth BDC Company Profile

TriplePoint Venture Growth BDC Corp. is a business development company that provides financing to venture growth-stage companies. The company primarily invests in businesses backed by venture capital or private equity sponsors, with an emphasis on companies that have developed products or services and are seeking capital to support expansion, acquisitions, working capital and other corporate purposes.

Its investment portfolio is focused largely on companies in technology, life sciences and other high-growth industries.